🔗 Share this article

The top legal official in Texas Paxton is suing the manufacturers of acetaminophen, alleging the firms hid alleged dangers that the pain reliever posed to pediatric neurological development.

This legal action arrives four weeks after Former President Trump promoted an unproven link between using Tylenol - alternatively called acetaminophen - throughout gestation and autism in children.

The attorney general is taking legal action against the pharmaceutical giant, which previously sold the drug, the only pain reliever recommended for expectant mothers, and the current manufacturer, which now manufacturers it.

In a official comment, he claimed they "misled consumers by gaining financially from suffering and promoting medication regardless of the potential hazards."

Kenvue says there is no credible evidence connecting acetaminophen to autism.

"These corporations misled for generations, deliberately risking numerous people to increase profits," the attorney general, from the Republican party, said.

The company commented that it was "deeply concerned by the spread of false claims on the security of paracetamol and the likely effects that could have on the well-being of US mothers and children."

On its online platform, the company also said it had "consistently assessed the relevant science and there is no credible data that indicates a established connection between consuming acetaminophen and autism spectrum disorder."

Associations acting on behalf of doctors and medical practitioners concur.

The leading OB-GYN organization has stated acetaminophen - the main ingredient in acetaminophen - is among limited choices for women during pregnancy to treat pain and elevated temperature, which can present major wellness concerns if not addressed.

"In multiple decades of studies on the utilization of acetaminophen in gestation, zero credible investigations has definitively established that the usage of paracetamol in any stage of pregnancy leads to neurological conditions in young ones," the association stated.

The lawsuit mentions current declarations from the former administration in asserting the drug is potentially dangerous.

Last month, the former president generated worry from medical authorities when he advised women during pregnancy to "resist strongly" not to take Tylenol when ill.

Federal regulators then released a statement that physicians should consider limiting the usage of acetaminophen, while also declaring that "a proven link" between the drug and autism spectrum disorder in young ones has not been established.

Health Secretary Kennedy, who supervises the Food and Drug Administration, had vowed in spring to conduct "extensive scientific investigation" that would determine the source of autism spectrum disorder in a matter of months.

But experts cautioned that discovering a sole reason of autism - believed by scientists to be the outcome of a intricate combination of genetic and surrounding conditions - would not be simple.

Autism is a type of enduring cognitive variation and impairment that influences how people experience and interact with the surroundings, and is recognized using medical professional evaluations.

In his legal document, the attorney general - who supports Trump who is running for US Senate - claims Kenvue and J&J "willfully ignored and sought to suppress the evidence" around paracetamol and autism.

This legal action aims to force the corporations "remove any commercial messaging" that states acetaminophen is safe for expectant mothers.

The court case echoes the concerns of a group of parents of minors with autism and ADHD who sued the manufacturers of Tylenol in recently.

Judicial authorities threw out the lawsuit, saying research from the plaintiffs' authorities was inconclusive.